Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Research findings from University of Hong Kong update understanding of cancer therapy
March 2nd, 2007
Investigators publish new data in the report "Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead. The development of gold(III) complexes as potential anticancer drugs with higher cytotoxicity and fewer side effects than existing metal anticancer drugs has been actively pursued in recent years. In this study, we explored the cellular pharmacological properties of gold(III) porphyrin 1a, an anticancer drug lead we previously described," investigators in People's Republic of China report. "The cytotoxicity study of gold(III) porphyrin 1a by naphthol blue black (NBB) staining assay demonstrated that the higher cytotoxicity of...
Source: Drug Week (2007-03-02)
|
